iPad
Alexion and Aide Health launch app for people with rare diseases
More than 3.5 million people in the UK live with a rare condition
UK drug repurposing study identifies several potential dementia treatments
An estimated 982,000 people in the UK are currently living with the neurodegenerative disease
AI tool better predicts progress of Alzheimer’s versus current clinical tests
The most common form of dementia accounts for up to 80% of all cases
Study identifies thousands of high-risk cancer gene variants and potential therapeutic target
Patients with inherited variants of the BAP1 gene have a 50% increased risk of developing certain cancers
Researchers’ new vaccine technology shows efficacy against broad range of coronaviruses
The vaccine provided protection against coronaviruses that have not yet emerged
New immune cell discovery could lead to personalised breast cancer treatments
The study revealed the key features of immune cells in helping the body’s immune system fight cancer
UK study reveals significantly higher risk of second cancers among breast cancer survivors
Breast cancer is currently the most commonly diagnosed cancer in the UK, affecting around 56,000 people annually
Single genetic test could replace current standard for diagnosing rare developmental disorders
The single genetic test could potentially replace the current standard and reduce costs for the NHS
Study reveals molecular signatures driving immune cell attacks in chronic neurological diseases
MS is a chronic neurological disease that affects more than two million people worldwide
Cambridge study reveals potential biomarker and target for long COVID treatments
The pro-inflammatory molecule, IFN-Y, persisted until symptoms improved in patients
Researchers uncover role of inherited genetic variants in rare blood cancer
There are around 4,000 cases of myeloproliferative neoplasms in the UK each year
Stem cell therapy trial shows promising results for treating progressive MS
The early-stage trial shows the potential to develop an advanced cell therapy treatment